NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.
Proof of principle needed before launching “big science” program, advisors say.
Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.
Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Benjamin Ebert, Amy Gladfelter, Stephen Liberles, and Pardis Sabeti are among new members of the National Academy of Sciences









